Ovarian aging: Mechanisms and clinical consequences

Endocrine Reviews

Volumn 30, Issue 5, 2009, Pages 465-493

  Broekmans, F J ^a   Soules, M R ^b   Fauser, B C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Seattle Reproductive Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

AGING; ASSISTIVE TECHNOLOGY; CONTRACEPTION; FEMALE FERTILITY; FEMALE INFERTILITY; FEMALE STERILITY; FERTILIZATION IN VITRO; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENOPAUSE; MENSTRUAL IRREGULARITY; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; OOCYTE; OVARIAN RESERVE; OVARY DEVELOPMENT; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PARTHENOGENESIS; PREGNANCY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REPRODUCTION; REVIEW;

AGING; BIOLOGICAL MARKERS; ENDOCRINE GLANDS; FEMALE; FERTILITY; HUMANS; MENSTRUAL CYCLE; OOCYTES; OVARY; PREGNANCY;

EID: 68549132328     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2009-0006     Document Type: Review

References (333)

1. Spira A 1988 The decline of fecundity with age. Maturitas (Suppl) 1:15-22
2. Wood JW 1989 Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 11:61-109
3. Abma JC, Chandra A, Mosher WD, Peterson LS, Piccinino LJ 1997 Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 23:1-114
4. Templeton A, Morris JK, Parslow W 1996 Factors that affect outcome of in vitro fertilisation treatment. Lancet 348:1402-1406
5. Centers for Disease Control and Prevention 2007 2005 Assisted reproductive technology success rates: National Summary and Fertility Clinic Reports. http://www.cdc.gov/ ART/ART2006/508PDF/2006ART.pdf
6. Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, Nygren KG 2009 Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society ofHumanReproductionand Embryology (ESHRE). Hum Reprod 24:1267-1287
7. Leridon H 2006 Demographic effects of the introduction of steroid contraception in developed countries.HumReprod Update 12:603-616
8. te Velde ER, Pearson PL 2002 The variability of female reproductive ageing. Hum Reprod Update 8:141-154
9. Eurostat 2006 Population and social conditions database. http://epp.eurostat.ec.europa.eu/cache/ITY-OFFPUB/KSRA-07-021/EN/ KS-RA-07-021-EN.PDF
10. Lutz W, O'Neill BC, Scherbov S 2003 Demographics. Europe's population at a turning point. Science 299:1991-1992
11. Lutz W 2006 Fertility rates and future population trends: will Europe's birth rate recover or continue to decline? Int J Androl 29:25-33
12. Gallo F, Hoorens S, Grant J, Cave J 2006 ShouldARTbe part of a population policy mix? A preliminary assessment of the demographic and economic impact of assisted reproductive technologies. Rand Corp. https://www. policyarchive.org/ handle/10207/7211
13. Ziebe S, Devroey P 2008 Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update 14:583-592
14. Evers JL 2002 Female subfertility. Lancet 360:151-159
15. Leridon H 2004 Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod 19:1548-1553
16. HabbemaJD, Eijkemans MJ, Nargund G, Beets G, Leridon H, Te Velde ER 2009 The effect of in vitro fertilization on birth rates in western countries. Hum Reprod 24:1414-1419
17. Hoorens S, Gallo F, Cave JA, Grant JC 2007 Can assisted reproductive technologies help to offset population ageing? An assessment of the demographic and economic impact of ART in Denmark and UK. Hum Reprod 22:2471-2475
18. Fauser BC, Devroey P, Macklon NS 2005 Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365:1807-1816
19. te Velde ER, Eijkemans MJ, Beets G, Habbema JD 2008 Can assisted reproductive technologies help to offset population ageing? Hum Reprod 23:2173-2174; author reply 2174-2175
20. Grant J, Hoorens S, Sivadasan S, LooMV,Davanzo J, Hale L, Butz W 2006 Trends in European fertility: should Europe try to increase its fertility rate or just manage the consequences? Int J Androl 29:17-24
21. Connolly MP, Pollard MS, Hoorens S, Kaplan BR, Oskowitz SP, Silber SJ 2008 Long-term economic benefits attributed to IVF-conceived children: a lifetime tax calculation. Am J Manag Care 14:598-604
22. Block E 1952 Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat (Basel) 14:108-123
23. Gougeon A, Chainy GB 1987 Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil 81:433-442
24. Richardson SJ, Senikas V, Nelson JF 1987 Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65:1231-1237
25. Jansen RP 1993 Relative infertility: modeling clinical paradoxes. Fertil Steril 59:1041-1045
26. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF1992Accelerated disappearance of ovarian follicles inmidlife: implications for forecasting menopause. Hum Reprod 7:1342-1346
27. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA 2008 A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 23:699-708
28. Kirkwood TB 1998 Ovarian ageing and the general biology of senescence. Maturitas 30:105-111
29. Leidy LE, Godfrey LR, Sutherland MR 1998 Is follicular atresia biphasic? Fertil Steril 70:851-859
30. Block E 1953 A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat (Basel) 17:201-206
31. Baker TG 1963 A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 158:417-433
32. Markström E, Svensson ECh, Shao R, Svanberg B, Billig H 2002 Survival factors regulating ovarian apoptosis-dependence on follicle differentiation. Reproduction 123:23-30
33. Faddy MJ, Gosden RG 1996 A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11:1484-1486
34. Faddy MJ 2000 Follicle dynamics during ovarian ageing. Mol Cell Endocrinol 163:43-48
35. Battaglia DE, Goodwin P, Klein NA, Soules MR 1996 Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod 11: 2217-2222
36. Kuliev A, Cieslak J, Verlinsky Y 2005 Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenet Genome Res 111:193-198
37. Hunt PA, Hassold TJ 2008 Human female meiosis: what makes a good egg go bad? Trends Genet 24:86-93
38. Pellestor F, Anahory T, Hamamah S 2005 Effect of maternal age on the frequency of cytogenetic abnormalities in human oocytes. Cytogenet Genome Res 111:206-212
39. Warburton D 2005 Biological aging and the etiology of aneuploidy. Cytogenet Genome Res 111:266-272
40. Schwartz D, Mayaux MJ 1982 Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 306:404-406
41. van Noord-Zaadstra BM, Looman CW, Alsbach H, Habbema JD, te Velde ER, Karbaat J 1991 Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ 302:1361-1365
42. Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER 2004 Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 11:607-614
43. O'Connor KA, Holman DJ, Wood JW 1998 Declining fecundity and ovarian ageing in natural fertility populations. Maturitas 30:127-136
44. Bouchard G 1994 Family reproduction in new rural areas: outline of a North American model. Can Hist Rev 75:475-510
45. Treloar AE, Boynton RE, Behn BG, BrownBW1967 Variation of the human menstrual cycle through reproductive life. Int J Fertil 12:77-126
46. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N 2001 Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76:
47. den Tonkelaar I, te Velde ER, Looman CW 1998 Menstrual cycle length preceding menopause in relation to age at menopause. Maturitas 29:115-123
48. Weinstein M, Gorrindo T, Riley A, Mormino J, Niedfeldt J, Singer B, Rodríguez G, Simon J, Pincus S 2003 Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 158:782-791
49. Treloar AE 1981 Menstrual cyclicity and the pre-menopause. Maturitas 3:249-264
50. VollmanRF1977 The menstrual cycle. Major Probl Obstet Gynecol 7:1-193
51. Leridon H, Spira A 1984 Problems in measuring the effectiveness of infertility therapy. Fertil Steril 41:580-586
52. Magurský V, Mesko M, Sokolík L 1975 Age at the menopause and onset of the climacteric in women of Martin District, Czechoslovkia. Statistical survey and some biological and social correlations. Int J Fertil 20:17-23
53. Bengtsson C, Lindquist O, Redvall L 1981 Menstrual status and menopausal age of middle-aged Swedish women.A population study of women in Goteborg 1968-69 and 1974-75. Acta Obstet Gynecol Scand 60:269-275
54. Hagstad A, Johansson S, Wilhelmsson C, Janson PO 1985 Gynaecology of middle-aged women-menstrual and reproductive histories. Maturitas 7:99-113
55. Luoto R, Kaprio J, Uutela A 1994 Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 139:64-76
56. van Noord PA, Dubas JS, Dorland M, Boersma H, te Velde E 1997 Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 68:95-102
57. de Vries E, den Tonkelaar I, van Noord PA, van der Schouw YT, te Velde ER, Peeters PH 2001 Oral contraceptive use in relation to age at menopause in the DOM cohort. Hum Reprod 16:1657-1662
58. van Asselt KM, Kok HS 2003 Age at menopause. A geneticepidemiological study. Academic thesis, Utrecht, The Netherlands
59. Lawlor DA, Ebrahim S, SmithGD2003 The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study. BJOG 110:1078-1087
60. Lisabeth L, Harlow S, Qaqish B 2004 A new statistical approach demonstrated menstrual patterns during the menopausal transition did not vary by age at menopause. J Clin Epidemiol 57:484-496
61. Eijkemans MJ, HabbemaJDF, te VeldeER2005 Age at last childbirth and fertility at young age. In: M.J. Eijkemans, ed. Fertility in populations and in patients. Academic thesis, Erasmus Medical Center, Rotterdam, The Netherlands; 23-34
62. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, van Leeuwen FE 2003 Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18:1544-1552
63. Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P 2003 Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 18: 527-533
64. Nikolaou D, Lavery S, Turner C, Margara R, TrewG2002 Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 17:1106-1111
65. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S, Randolph JF Jr 2008 Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 93:3478-3483
66. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER 2004 Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11: 601-606
67. Bouchard G 2000 Through the meshes of patriarchy: the male/female relationship in the Saguenay peasant society (1860-1930). 4th ed. New York: Elsevier Science Inc.; 397-425
68. GougeonA1984 Caracteres qualitatifs et quantitatifs de la population folliculaire dans l'ovaire humaine adulte. Contracept Fertil Sex 12:527-535
69. Gougeon A 1996 Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 17: 121-155
70. Pache TD, Wladimiroff JW, de Jong FH, Hop WC, Fauser BC 1990 Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 54: 638-642
71. Ruess ML, Kline J, Santos R, Levin B, Timor-Tritsch I 1996 Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am-J-Obstet-Gynecol 174:624-627
72. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER 1999 Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72:845-851
73. Meldrum DR, Chetkowski RJ, Steingold KA, Randle D 1984 Transvaginal ultrasound scanning of ovarian follicles. Fertil Steril 42:803-805
74. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER 2004 Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril 81:35-41
75. Hansen KR, Morris JL, Thyer AC, Soules MR 2003 Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril 80:577-583
76. Scheffer GJ, Broekmans FJ, Bancsi LF, Habbema JD, LoomanCW,Te VeldeER2002 Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol 20:270-275
77. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER 2002 Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77: 328-336
78. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH 1998 Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 69:505-510
79. Ng EH, Tang OS, Ho PC 2000 The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Hum Reprod 15: 1937-1942
80. Gougeon A 1986 Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1:81-87
81. Westergaard L, Christensen IJ, McNatty KP 1986 Steroid levels in ovarian follicular fluid related to follicle size and health status during the normal menstrual cycle in women. Hum Reprod 1:227-232
82. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ 2005 Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a metaanalysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 83:291-301
83. Hirshfield AN 1989 Rescue of atretic follicles in vitro and in vivo. Biol Reprod 40:181-190
84. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan TS, Baird DT, McNeilly AS 1994 Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 40:717-723
85. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401-1405
86. Hall JE, Welt CK, CramerDW1999 Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14:409-415
87. Stouffer RL, Dahl KD, Hess DL, Woodruff TK, Mather JP, Molskness TA 1994 Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle. Biol Reprod 50:888-895
88. Fraser HM, TsonisCG1994 Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion. J Endocrinol 142:181-186
89. Findlay JK 1993 An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 48:15-23
90. Findlay JK, Drummond AE, Britt KL, Dyson M, Wreford NG, Robertson DM, Groome NP, Jones ME, Simpson ER 2000 The roles of activins, inhibins and estrogen in early committed follicles. Mol Cell Endocrinol 163:81-87
91. Hillier SG 1991 Regulatory functions for inhibin and activin in human ovaries. J Endocrinol 131:171-175
92. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE 2002 A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 77:978-985
93. Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA 1997 Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome [see comments]. Fertil Steril 67:110-114
94. Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, te Jong FH, teVelde ER 2003 The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700-706
95. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER 2005 Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83: 979-987
96. Burger HG, Hale GE, Robertson DM, Dennerstein L 2007 Areview of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 13:559-565
97. Vigier B, Tran D, Legeai L, Bézard J, Josso N 1984 Origin of anti-Mullerian hormone in bovine freemartin fetuses. J Reprod Fertil 70:473-479
98. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 2001 Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891-4899
99. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 1999 Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140:5789-5796
100. Weenen C, Laven JS,VonBergh AR, CranfieldM,Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10:77-83
101. Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born BM, de Jong FH, Groome NP, Themmen AP, Visser JA 2006 Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147:3228-3234
102. Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J 2003 Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18:323-327
103. Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D 2007 Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J Clin Endocrinol Metab 92:4138-4143
104. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77:357-362
105. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP 2002 Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17:3065-3071
106. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM 2002 Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77:468-471
107. Fanchin R, Schonäuer LM, Righini C, Frydman N, Frydman R, Taieb J 2003 Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 18:328-332
108. van Disseldorp J, Broekmans FJ, Peeters PH, Fauser BC, van der Schouw YT 2008 The association between vascular function-related genes and age at natural menopause. Menopause 15:511-516
109. Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, Beerendonk CC, Laven JS, Goverde AJ, Broekmans FJ,ThemmenAP, de Jong FH, FauserBC2009 Anti Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 94:786-792
110. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ 2006 Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91: 4057-4063
111. Cook CL, Siow Y, Taylor S, Fallat ME 2000 Serum Mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73:859-861
112. La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A 2007 Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod 22:766-771
113. La Marca A, Stabile G, Artenisio AC, VolpeA2006 Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 21:3103-3107
114. Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy Ch, Englert Y 2007 Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 22:1837-1840
115. Fauser BC, Van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18:71-106
116. Buffet NC, Bouchard P 2001 The neuroendocrine regulation of the human ovarian cycle. Chronobiol Int 18:893-919
117. de Koning CH, McDonnell J, Themmen AP, de Jong FH, Homburg R, Lambalk CB 2008 The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls. Hum Reprod 23: 1416-1423
118. van Santbrink EJ, Hop WC, van Dessel TJ, de Jong FH, FauserBC1995 Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 64:37-43
119. Welt CK, Smith ZA, Pauler DK, Hall JE 2001 Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab 86:2531-2537
120. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C 1985 The ovarian androgen producing cells: a review of structure/ function relationships. Endocr Rev 6:371-399
121. van Zonneveld P, Scheffer GJ, Broekmans FJ, Blankenstein MA, de Jong FH, Looman CW, Habbema JD, te Velde ER 2003 Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum Reprod 18:495-501
122. Burger HG, Hale GE, Dennerstein L, RobertsonDM2008 Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 15:603-612
123. Burger H 2008 The menopausal transition- endocrinology. J Sex Med 5:2266-2273
124. Miro F, Parker SW, Aspinall LJ, Coley J, Perry PW, Ellis JE 2005 Sequential classification of endocrine stages during reproductive aging in women: the FREEDOM study. Menopause 12:281-290
125. Metcalf MG, Donald RA, Livesey JH 1982 Pituitary-ovarian function before, during and after the menopause: a longitudinal study. Clin Endocrinol (Oxf) 17:489-494
126. Sherman BM, West JH, Korenman SG 1976 The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42:629-636
127. Hall JE, WhitcombRW,Rivier JE, ValeWW,CrowleyWFJr 1990 Differential regulation of luteinizing hormone, folliclestimulating hormone, and free α-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. J Clin Endocrinol Metab 70:328-335
128. Hall JE 2004 Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am 33: 637-659
129. MetcalfMG,LiveseyJH1985 Gonadotrophin excretion in fertile women: effect of age and the onset of the menopausal transition. J Endocrinol 105:357-362
130. Wise PM, Smith MJ, Dubal DB, Wilson ME, Rau SW, Cashion AB, Böttner M, Rosewell KL 2002 Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog Horm Res 57:235-256
131. Bellino FL, Wise PM 2003 Nonhuman primate models of menopause workshop. Biol Reprod 68:10-18
132. Rehman HU, Masson EA 2005 Neuroendocrinology of female aging. Gend Med 2:41-56
133. Yin W, Gore AC 2006 Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction 131: 403-414
134. Nozaki M, Mitsunaga F, Shimizu K 1995 Reproductive senescence in female Japanese monkeys (Macaca fuscata): age- and season-related changes in hypothalamic-pituitary-ovarian functions and fecundity rates. Biol Reprod 52:1250-1257
135. Gill S, Sharpless JL, Rado K, Hall JE 2002 Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab 87:2290-2296
136. Hall JE, Lavoie HB, Marsh EE, Martin KA 2000 Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab 85:1794-1800
137. RossmanithWG1995 Gonadotropin secretion during aging in women: review article. Exp Gerontol 30:369-381
138. Kwekkeboom DJ, de Jong FH, van Hemert AM, Vandenbroucke JP, Valkenburg HA, Lamberts SW 1990 Serum gonadotropins and α-subunit decline in aging normal postmenopausal women. J Clin Endocrinol Metab 70:944-950
139. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ 2004 Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 292:2991-2996
140. Vvan Look PF, Lothian H, Hunter WM, Michie EA, Baird DT 1977 Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol (Oxf) 7:13-31
141. Tanaka Y, Katayama K, Tojo S 1982 [Failure of positive feedback in hypothalamo-pituitary-system in aged women and its recovery with estrogen treatment]. Nippon Sanka Fujinka Gakkai Zasshi 34:1907-1915
142. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N 1995 Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab 80:608-613
143. de Koning CH, Popp-Snijders C, Schoemaker J, Lambalk CB 2000 Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH.HumReprod 15:1452-1456
144. Matt DW, Kauma SW, Pincus SM, Veldhuis JD, EvansWS 1998 Characteristics of luteinizing hormone secretion in younger versus older premenopausal women.AmJ Obstet Gynecol 178:504-510
145. Klein NA, Battaglia DE, Clifton DK, Bremner WJ, Soules MR 1996 The gonadotropin secretion pattern in normal women of advanced reproductive age in relation to the monotropic FSH rise. J Soc Gynecol Investig 3:27-32
146. Reame NE, Kelche RP, Beitins IZ, Yu MY, Zawacki CM, Padmanabhan V 1996 Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab 81:1512-1518
147. Randolph JF, Ginsburg KA, Leach RE, Blacker CM, Moghissi KS, Diamond MP, Reame NE 2003 Elevated early follicular gonadotropin levels in women with unexplained infertility do not provide evidence for disordered gonadotropin-releasing hormone secretion as assessed by luteinizing hormone pulse characteristics. Fertil Steril 80: 320-327
148. Eshkol A, Lunenfeld B, Insler V 1975 The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone. J Steroid Biochem 6:1061-1066
149. FujimotoVY,KleinNA,Battaglia DE, Bremner WJ, Soules MR 1996 The anterior pituitary response to a gonadotropin-releasing hormone challenge test in normal older reproductive-age women. Fertil Steril 65:539-544
150. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR 1996 Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibinAand B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:2742-2745
151. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR 1996 Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 81:1038-1045
152. Welt CK, McNicholl DJ, Taylor AE, Hall JE 1999 Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84:105-111
153. Muttukrishna S, Child T, Lockwood GM, Groome NP, Barlow DH, Ledger WL 2000 Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women. Hum Reprod 15:549-556
154. Klein NA, Houmard BS, Hansen KR, Woodruff TK, Sluss PM, Bremner WJ, Soules MR 2004 Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 89:2977-2981
155. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM,Fraser IS 2007 Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 92:3060-3067
156. Kwee J, Elting MW, Schats R, Bezemer PD, Lambalk CB, Schoemaker J 2003 Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod 18:1422-1427
157. Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, Gal M, Zylber-Haran E, Margalioth EJ 2005 Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.Hum Reprod 20:3178-3183
158. Haadsma ML, Bukman A, Groen H, Roeloffzen EM, Groenewoud ER, Heineman MJ, Hoek A 2007 The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod 22:1925-1931
159. Grynberg M, Feyereisen E, Scheffer JB, Koutroubis P, Frydman R, Fanchin R 4 December 2008 Early follicle development alters the relationship between antral follicle counts and inhibin B and follicle-stimulating hormone levels on cycle day 3. Fertil Steril 10.1016/j.fertnstert.2008.10.025
160. MacNaughton J, Banah M, McCloud P, Hee J, Burger H 1992 Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol (Oxf) 36:339-345
161. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, Dennerstein L, MorseC 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80: 3537-3545
162. Burger HG, Groome NP, Robertson DM 1998 Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 83:4167-4169
163. Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM 2004 Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 89:2763-2769
164. Beemsterboer SN, Homburg R, Gorter NA, Schats R, Hompes PG, Lambalk CB 2006 The paradox of declining fertility but increasing twinning rates with advancing maternal age. Hum Reprod 21:1531-1532
165. Hoekstra C, Zhao ZZ, Lambalk CB, Willemsen G, Martin NG, Boomsma DI, Montgomery GW 2008 Dizygotic twinning. Hum Reprod Update 14:37-47
166. Lee SJ, Lenton EA, Sexton L, Cooke ID 1988 The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3:851-855
167. Metcalf MG, Livesey JH 1988 Pregnanediol excretion in fertile women: age-related changes. J Endocrinol 119:153-157
168. Mersereau JE, Evans ML, Moore DH, Liu JH, Thomas MA, Rebar RW, Pennington E, Cedars MI 2008 Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women. Menopause 15:482-486
169. Pal L, Zhang K, Zeitlian G, Santoro N 18 December 2008 Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril 10.1016/j.fertnstert.2008.10.069
170. Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG 1994 Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous
171. Reyes FI, Winter JS, Faiman C 1977 Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 129:557-564
172. Reame NE, Wyman TL, Phillips DJ, de Kretser DM, Padmanabhan V 1998 Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin Amay contribute in part to the rise in follicular phase folliclestimulating hormone of aging cycling women. J Clin Endocrinol Metab 83:3302-3307
173. Danforth DR, Arbogast LK, Mroueh J, KimMH,Kennard EA, Seifer DB, Friedman CI 1998 Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 70:119-123
174. Lahlou N, Chabbert-Buffet N, Christin-Maitre S, Le Nestour E, Roger M, Bouchard P 1999 Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B? Hum Reprod 14: 1190-1193
175. Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS 2009 Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Menopause 16:50-59
176. Klein NA, Battaglia DE, Miller PB, Branigan EF, Giudice LC, Soules MR 1996 Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J Clin Endocrinol Metab 81:1946-1951
177. Davison SL, Bell R, Donath S, Montalto JG, DavisSR2005 Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90: 3847-3853
178. Spencer JB, Klein M, Kumar A, Azziz R 2007 The ageassociated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab 92:4730-4733
179. Hansen KR, Thyer AC, Sluss PM, Bremner WJ, Soules MR, Klein NA 2005 Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women? Hum Reprod 20:89-95
180. Klein NA, Harper AJ, Houmard BS, Sluss PM, SoulesMR 2002 Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J Clin Endocrinol Metab 87:5746-5750
181. FosterCM,Olton PR, RacineMS,Phillips DJ,Padmanabhan V 2004 Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment. Hum Reprod 19:1668-1676
182. Lenton EA, Landgren BM, Sexton L, Harper R 1984 Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 91:681-684
183. Miro F, Aspinall LJ 2005 The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle. Hum Reprod 20:96-100
184. Dursun P, Gultekin M, Yuce K, Ayhan A 2006 What is the underlying cause of aneuploidy associated with increasing maternal age? Is it associated with elevated levels of gonadotropins? Med Hypotheses 66:143-147
185. McTavish KJ, Jimenez M, Walters KA, Spaliviero J, Groome NP, Themmen AP, Visser JA, Handelsman DJ, AllanCM2007 Rising follicle-stimulating hormone levels with age accelerate female reproductive failure. Endocrinology 148:4432-4439
186. Jamnongjit M, Hammes SR 2005 Oocyte maturation: the coming of age of a germ cell. Semin Reprod Med 23:234-241
187. Mehlmann LM 2005 Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation. Reproduction 130: 791-799
188. Hunt PA, Hassold TJ 2002 Sex matters in meiosis. Science 296:2181-2183
189. Andreu-Vieyra C, Lin YN, MatzukMM2006 Mining the oocyte transcriptome. Trends Endocrinol Metab 17:136-143
190. Gilchrist RB, Lane M, Thompson JG 2008 Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 14:159-177
191. Delhanty JD 2005 Mechanisms of aneuploidy induction in human oogenesis and early embryogenesis. Cytogenet Genome Res 111:237-244
192. Pellestor F, Andréo B, Anahory T, Hamamah S 2006 The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur J Med Genet 49: 103-116
193. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL 2005 Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Genet 76:91-99
194. Macklon NS, Geraedts JP, Fauser BC 2002 Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update 8:333-343
195. Volarcik K, Sheean L, Goldfarb J, Woods L, Abdul-Karim FW, Hunt P 1998 The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum Reprod 13:154-160
196. Jones KT 2008 Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age.HumReprod Update 14:143-158
197. Ottolenghi C, Uda M, Hamatani T, Crisponi L, Garcia JE, Ko M, Pilia G, Sforza C, Schlessinger D, ForaboscoA2004 Aging of oocyte, ovary, and human reproduction. AnnNY Acad Sci 1034:117-131
198. Oliver TR, Feingold E, Yu K, Cheung V, Tinker S, Yadav-Shah M, Masse N, Sherman SL 2008 New insights into humannondisjunction of chromosome 21 in oocytes. PLoS Genet 4:e1000033
199. 1995 Pregnancies and births resulting from in vitro fertilization: French national registry, analysis of data 1986 to 1990. FIVNAT (French In Vitro National). Fertil Steril 64:746-756
200. Viudes-de-Castro MP, Vicente JS 1997 Effect of sperm count on the fertility and prolificity rates of meat rabbits. Anim Reprod Sci 46:313-319
201. Mocé E, Lavara R, Vicente JS 2005 Influence of the donor male on the fertility of frozen-thawed rabbit sperm after artificial insemination of females of different genotypes. Reprod Domest Anim 40:516-521
202. Menken J, Trussell J, Larsen U 1986 Age and infertility. Science 233:1389-1394
203. Coulam CB, Adamson SC, Annegers JF 1986 Incidence of premature ovarian failure. Obstet Gynecol 67:604-606
204. Beck-Peccoz P, Persani L 2006 Premature ovarian failure. Orphanet J Rare Dis 1:9
205. Welt CK 2008 Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 68:499-509
206. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT 2006 Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a metaanalysis. Menopause 13:265-279
207. Jacobsen BK, Heuch I, KvåleG2004 Age at natural menopause and stroke mortality: cohort study with 3561 stroke deaths during 37-year follow-up. Stroke 35:1548-1551
208. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD 1996 Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718
209. van Der Voort DJ, van Der Weijer PH, Barentsen R 2003 Early menopause: increased fracture risk at older age. Osteoporos Int 14:525-530
210. van Wayenburg CA, van der Schouw YT, van Noord PA, Peeters PH 2000 Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. epidemiology 11:304-308
211. van der Stege JG, Groen H, van Zadelhoff SJ, Lambalk CB, Braat DD, van Kasteren YM, van Santbrink EJ, Apperloo MJ, Weijmar Schultz WC, Hoek A 2008 Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 15:23-31
212. Rocca WA, Shuster LT, Grossardt BR, Maraganore DM, Gostout BS, Geda YE, Melton LJ 3rd 2009 Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) 5:39-48
213. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
214. Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, van der Graaf Y, Grobbee DE, van der Schouw YT 2005 Age at menopause, cause-specific mortality and total life expectancy. epidemiology 16:556-562
215. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA 2008 Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol 9:239-246
216. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA 2008 Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93:4735-4742
217. Rees MC 2008 Premature menopause: hormone replacement therapy is indeed indicated. BMJ 336:1148
218. Lewars MD 2008 Premature menopause: article's recommendation ofHRTis highly questionable.BMJ336:1033-1034
219. Rebar RW 2008 Premature ovarian "failure" in the adolescent. Ann NY Acad Sci 1135:138-145
220. Welt CK, Smith PC, Taylor AE 2004 Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 89:4569-4574
221. Simpson JL, Rajkovic A 1999 Ovarian differentiation and gonadal failure. Am J Med Genet 89:186-200
222. WittenbergerMD,HagermanRJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM 2007 The FMR1 premutation and reproduction. Fertil Steril 87:456-465
223. Nelson LM 2009 Clinical practice. Primary ovarian insufficiency. N Engl J Med 360:606-614
224. Simpson JL 2008 Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann NY Acad Sci 1135:146-154
225. Fassnacht W, Mempel A, Strowitzki T, Vogt PH 2006 Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. CurrMed Chem 13:1397-1410
226. Woad KJ, Watkins WJ, Prendergast D, Shelling AN 2006 The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol 46:242-244
227. Nelson LM, Covington SN, Rebar RW 2005 An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 83:1327-1332
228. van Kasteren YM, Schoemaker J 1999 Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 5:483-492
229. Sauer MV, Kavic SM 2006 Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 12:153-162
230. Sun W, Stegmann BJ, Henne M, Catherino WH, Segars JH 2008 A new approach to ovarian reserve testing. Fertil Steril 90:2196-2202
231. Henne MB, Stegmann BJ, Neithardt AB, Catherino WH, Armstrong AY, Kao TC, Segars JH 2008 The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology. Fertil Steril 89:104-110
232. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB 2006 A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12:685-718
233. Hendriks DJ, Broekmans FJ, Bancsi LF, Looman CW, de Jong FH, te Velde ER 2005 Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet 22:65-73
234. Hendriks DJ,MolBW,Bancsi LF, te Velde ER, Broekmans FJ 2006 The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review. Fertil Steril 86:807-818
235. Jain T, Soules MR, Collins JA 2004 Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 82:180-185
236. Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, te Velde ER 2003 Performance of basal follicle-stimulating hormonein the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79:1091-1100
237. Broer SL, Mol BW, Hendriks D, Broekmans FJ 2009 The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 91:705-714
238. Hendriks DJ, Kwee J, MolBW,te Velde ER, Broekmans FJ 2007 Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 87:764-775
239. Verhagen TE, Hendriks DJ, Bancsi LF,MolBW,Broekmans FJ2008Theaccuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a metaanalysis. Hum Reprod Update 14:95-100
240. TanboT, Dale PO, Lunde O,NormanN, AbyholmT1992 Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril 57: 819-824
241. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K 1990 Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 53:295-301
242. Ragni G, Chiaffarino F, Scarduelli C, Bonetti S, Nicolosi AE, Arnoldi M, Somigliana E 2008 The clomiphene citrate challenge test (CCCT) in women with elevated basal FSH: biological significance and predictive value. Eur J Obstet Gynecol Reprod Biol 141:44-48
243. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R 1994 Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod 9:1607-1611
244. Yong PY, Baird DT, Thong KJ, McNeilly AS, Anderson RA 2003 Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod 18: 35-44
245. Kwee J, Schats R, McDonnell J, Lambalk CB, Schoemaker J 2004 Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod 19:590-595
246. Broekmans FJ, Bernardus RE, Broeders A, Berkhout G, Schoemaker J 1993 Pituitary responsiveness after administration of aGnRHagonist depot formulation: decapeptyl CR. Clin Endocrinol (Oxf) 38:579-587
247. Padilla SL, Bayati J, Garcia JE 1990 Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 53:288-294
248. Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ 1991 The gonadotropin-releasing hormoneagonist stimulation test-a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 56:711-717
249. RanieriDM,Quinn F, Makhlouf A, Khadum I, Ghutmi W, McGarrigle H, Davies M, Serhal P 1998 Simultaneous evaluation of basal follicle-stimulating hormone and 17 β-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 70:227-233
250. Harrison RF, Jacob S, Spillane H, Mallon E, Hennelly B 2001 A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-β) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles. Fertil Steril 75:23-31
251. Klinkert ER, Broekmans FJ, LoomanCW,Habbema JD, te Velde ER 2005 Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 20:611-615
252. Popovic-Todorovic B, Loft A, Ziebe S, AndersenAN2004 Impact of recombinant FSH dose adjustments on ovarian response in the second treatment cycle with IVF or ICSI in "standard" patients treated with 150 IU/day during the first cycle. Acta Obstet Gynecol Scand 83:842-849
253. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J 2003 Clinical management of low ovarian response to stimulation for IVF: a systematic review.HumReprod Update 9:61-76
254. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, TarlatzisBC2009Howto improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril 91:749-766
255. KlinkertER2005 Clinical significance and management of poor response in IVF. Academic thesis, University Medical Center, Utrecht, The Netherlands
256. Barrenetxea G, Agirregoikoa JA, JiménezMR,de Larruzea AL, Ganzabal T, CarboneroK2008 Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 89:546-553
257. Mochtar MH, Van der Veen, Ziech M, van WelyM2007 Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev CD005070
258. Scott RT Jr, Elkind-Hirsch KE, Styne-Gross A, Miller KA, Frattarelli JL 2008 The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone. Fertil Steril 89:868-878
259. van Rooij IA, de Jong E, Broekmans FJ, Looman CW, HabbemaJD, teVeldeER2004Highfollicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril 81:1478-1485
260. Lashen H, Ledger W, Lopez-Bernal A, Barlow D 1999 Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod 14:964-969
261. Zhen XM, Qiao J, Li R, Wang LN, Liu P 2008 The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples. J Assist Reprod Genet 25:17-22
262. Hendriks DJ, te Velde ER, Looman CW, Bancsi LF, Broekmans FJ 2008 Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool. Reprod Biomed Online 17:727-736
263. Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC 2007 Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 18:58-65
264. Thomas F, Renaud F, Benefice E, de Meeüs T, Guegan JF 2001 International variability of ages at menarche and menopause: patterns and main determinants. Hum Biol 73:271-290
265. Parazzini F, Progetto Menopausa Italia Study Group 2007 Determinants of age at menopause in women attending menopause clinics in Italy. Maturitas 56:280-287
266. Soares SR, Melo MA 2008 Cigarette smoking and reproductive function. Curr Opin Obstet Gynecol 20:281-291
267. de Bruin JP, Bovenhuis H, van Noord PA, Pearson PL, van Arendonk JA, te Velde ER, Kuurman WW, Dorland M 2001 The role of genetic factors in age at natural menopause. Hum Reprod 16:2014-2018
268. Treloar SA, Sadrzadeh S,DoKA, MartinNG,LambalkCB 2000 Birth weight and age at menopause in Australian female twin pairs: exploration of the fetal origin hypothesis. Hum Reprod 15:55-59
269. Kok HS, van Asselt KM, van der Schouw YT, Peeters PH, Wijmenga C 2005 Genetic studies to identify genes underlying menopausal age. Hum Reprod Update 11:483-493
270. van Asselt KM, Kok HS, Pearson PL, Dubas JS, Peeters PH, TeVeldeER,vanNoordPA2004Heritability ofmenopausal age in mothers and daughters. Fertil Steril 82:1348-1351
271. Murabito JM,YangQ, Fox C, WilsonPW,CupplesLA2005 Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab 90:3427-3430
272. Torgerson DJ, Thomas RE, Reid DM 1997 Mothers and daughters menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Biol 74:63-66
273. Wicks J, Treloar SA, Martin NG 2004 Using identity-bydescent information in affected sib pairs to increase the efficiency of genetic association studies. Twin Res 7:211-216
274. Laissue P, Lakhal B, Benayoun BA, Dipietromaria A, Braham R, Elghezal H, Philibert P, Saad A, Sultan C, Fellous M, Veitia R 7 May 2009 Functional evidence implicating FOXL2 in non syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J Med Genet 10.1136/jmg.2008. 065086
275. Laissue P, Vinci G, Veitia RA, Fellous M 2008 Recent advances in the study of genes involved in non-syndromic premature ovarian failure. Mol Cell Endocrinol 282:101-111
276. Skillern A, Rajkovic A 2008 Recent developments in identifying genetic determinants of premature ovarian failure. Sex Dev 2:228-243
277. Knauff EA, Franke L, van EsMA,van den Berg LH, van der Schouw YT, Laven JSE., Lambalk CB, Hoek A, Goverde AJ, Christin-Maitre S, Hsueh A, Wijmenga C, Fauser BC 9 June 2009 Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod 10.1093/humrep/dep197
278. McCarroll SA 2008 Extending genome-wide association studies to copy-number variation. Hum Mol Genet 17: R135-R142
279. Knauff EA, Wijmenga C, van't Slot R, Franke L, FauserBC 2009 Genome wide high density SNP-CGH reveals several new deletion copy number variants on the X chromosome in POF patients. Reprod Sci 15:601
280. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M 2007 Penn CNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17:1665-1674
281. Rodriguez-Revenga L, Mila M, Rosenberg C, Lamb A, Lee C 2007 Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet Med 9:600-606
282. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty B, Singh L 2006 Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 119:408-415
283. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, Cavallo L, Einaudi S, Radetti G, Russo G, Sacco M, Wasniewska M, Cole T, Beck-Peccoz P, Nelson LM, Persani L 2006 Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 91:1976-1979
284. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R, Dewailly D, Reyss AC, Jeffery L, Bachelot A, Massin N, Fellous M, Veitia RA 2006 Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 154:739-744
285. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, TreierM2004 The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933-942
286. Willer CJ, Scott LJ, Bonnycastle LL, Jackson AU, Chines P, Pruim R, Bark CW, Tsai YY, Pugh EW, Doheny KF, Kinnunen L, Mohlke KL, Valle TT, Bergman RN, Tuomilehto J, Collins FS, BoehnkeM2006 Tag SNP selection for Finnish individuals based on the CEPH Utah HapMap database. Genet Epidemiol 30:180-190
287. International HapMap Consortium 2005 A haplotype map of the human genome. Nature 437:1299-1320
288. Lakhal B, Laissue P, Braham R, Elghezal H, Saad A, Fellous M, Veitia RA 8 June 2009 BMP15 and premature ovarian failure: causal mutations, variants, polymorphisms? Clin Endocrinol (Oxf) 10.1111/j.1365-2265.2009.03651.x
289. Tempfer CB, Riener EK, Keck C, Grimm C, Heinze G, Huber JC, Gitsch G, Hefler LA 2005 Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women. Menopause 12:325-330
290. van Asselt KM, Kok HS, Peeters PH, Roest M, Pearson PL, te Velde ER, Grobbee DE, van der SchouwYT2003 Factor V Leiden mutation accelerates the onset of natural menopause. Menopause 10:477-481
291. Pripp U, Eriksson-Berg M, Orth-Gomér K, Schenck-Gustafsson K, LandgrenBM2005 Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women? Gend Med 2:88-95
292. Kok HS, van Asselt KM, van der Schouw YT, van der Tweel I, Peeters PH, Wilson PW, Pearson PL, Grobbee DE 2006 Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 47:1976-1983
293. Koochmeshgi J, Hosseini-Mazinani SM, Morteza Seifati S, Hosein-Pur-Nobari N, Teimoori-Toolabi L 2004 Apolipoprotein E genotype and age at menopause. Ann NY Acad Sci 1019:564-567
294. Huber A, Grimm C, Huber JC, Schneeberger C, Leodolter S, Reinthaller A, Tempfer CB, Hefler LA 2006 A common polymorphism within the steroid 5-α-reductase type 2 gene and timing of menopause in Caucasian women. Eur J Obstet Gynecol Reprod Biol 125:221-225
295. Tarín JJ 1995 Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'. Hum Reprod 10:1563-1565
296. Van Blerkom J, Antczak M, Schrader R 1997 The developmental potential of the human oocyte is related to the dissolvedoxygencontent of follicular fluid: associationwithvascular endothelial growth factor levelsandperifollicular blood flow characteristics. Hum Reprod 12:1047-1055
297. Gaulden ME 1992 Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res 296:69-88
298. Hefler LA, Grimm C, Heinze G, Schneeberger C, Mueller MW, Muendlein A, Huber JC, Leodolter S, Tempfer CB 2005 Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod 20:1422-1427
299. Weel AE, Uitterlinden AG, Westendorp IC, Burger H, Schuit SC, Hofman A, Helmerhorst TJ, van Leeuwen JP, Pols HA 1999 Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84:3146-3150
300. Kok HS, Onland-Moret NC, van Asselt KM, van Gils CH, van der Schouw YT, Grobbee DE, Peeters PH 2005 No association of estrogen receptor α and cytochrome P450c17α polymorphisms with age at menopause in a Dutch cohort. Hum Reprod 20:536-542
301. Gorai I, Tanaka K, Inada M, Morinaga H, Uchiyama Y, Kikuchi R, Chaki O, Hirahara F 2003 Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-α gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab 88:799-803
302. van Asselt KM, Kok HS, Putter H, Wijmenga C, Peeters PH, van der Schouw YT, Grobbee DE, te Velde ER, Mosselman S, Pearson PL 2004 Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age. Am J Hum Genet 74:444-453
303. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, Seliger E, Röpke F, Gromoll J, Nieschlag E, SimoniM2005 Significance of acommonsingle nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 15:451-456
304. Zerbetto I, Gromoll J, Luisi S, Reis FM, Nieschlag E, Simoni M, Petraglia F 2008 Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. Fertil Steril 90:2264-2268
305. Kevenaar ME, Themmen AP, Rivadeneira F, Uitterlinden AG, Laven JS, van Schoor NM, Lips P, Pols HA, Visser JA 2007 A polymorphism in theAMHtype II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 22:2382-2388
306. Hsu SY, Hsueh AJ 2000 Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 80: 593-614
307. Petros AM, Olejniczak ET, Fesik SW 2004 Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644:83-94
308. Atwood LD, Heard-Costa NL 2003 Limits of fine-mapping a quantitative trait. Genet Epidemiol 24:99-106
309. Hirschhorn JN, Daly MJ 2005 Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6:95-108
310. Stolk L, Zhai G, van Meurs JB, Verbiest MM, Visser JA, Estrada K, Rivadeneira F, Williams FM, Cherkas L, Deloukas P, Soranzo N, de Keyzer JJ, Pop VJ, Lips P, Lebrun CE, van der Schouw YT, Grobbee DE, Witteman J, Hofman A, Pols HA, Laven JS, Spector TD, Uitterlinden AG 17 May 2009 Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 41:645-647
311. He C, Kraft P, Chen C, Buring JE, Pare G, Hankinson SE, Chanock SJ, Ridker PM, Hunter DJ, Chasman DI 2009 Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet 41:724-728
312. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, González JR, Gratacòs M, Huang J, Kalaitzopoulos D,KomuraD, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Zhang J, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, CarterNP,AburataniH, Lee C, JonesKW, Scherer SW, HurlesME2006 Global variation in copy number in the human genome. Nature 444:444-454
313. Feuk L, Carson AR, Scherer SW 2006 Structural variation in the human genome. Nat Rev Genet 7:85-97
314. Barnett KR, Schilling C, Greenfeld CR, Tomic D, Flaws JA 2006 Ovarian follicle development and transgenic mouse models. Hum Reprod Update 12:537-555
315. Cate RL, Mattaliano RJ, Hession C, Tizard R, FarberNM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP 1986 Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685-698
316. MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK 1992 Mullerian duct regression and antiproliferative bioactivities of Mullerian inhibiting substance reside in its carboxy-terminal domain. Endocrinology 131:291-296
317. Nachtigal MW, IngrahamHA1996 Bioactivation of Mullerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc Natl Acad Sci USA 93:7711-7716
318. Donahoe PK, Clarke T, Teixeira J, Maheswaran S, MacLaughlin DT 2003 Enhanced purification and production of Mullerian inhibiting substance for therapeutic applications. Mol Cell Endocrinol 211:37-42
319. Pieretti-Vanmarcke R, Donahoe PK, Pearsall LA, Dinulescu DM, Connolly DC, Halpern EF, Seiden MV, MacLaughlin DT2006Mullerianinhibiting substanceenhancessubclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proc Natl Acad Sci USA 103:17426-17431
320. Pieretti-Vanmarcke R, Donahoe PK, Szotek P, Manganaro T, Lorenzen MK, Lorenzen J, Connolly DC, Halpern EF, MacLaughlin DT 2006 Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo. Clin Cancer Res 12:1593-1598
321. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK 2006 Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 103:11154-11159
322. Martins FS, Celestino JJ, SaraivaMV,MatosMH,Bruno JB, Rocha-Junior CM, Lima-Verde IB, Lucci CM, Báo SN, FigueiredoJR2008Growthanddifferentiation factor-9 stimulates activation of goat primordial follicles in vitro and their progression tosecondaryfollicles. ReprodFertilDev20:916-924
323. Orisaka M, Jiang JY, Orisaka S, Kotsuji F, Tsang BK 2009 Growth Differentiation Factor 9 Promotes Rat Preantral Follicle Growth by Up-regulating Follicular Androgen Biosynthesis. Endocrinology 150:2740-2748
324. Bouchard G 1989 Population studies and genetic epidemiology in northeast Quebec. Can Stud Popul 16:61-86
325. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R 2002 European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113-1124
326. Farhi J,HomburgR, Ferber A, Orvieto R, Ben RafaelZ1997 Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 12:241-243
327. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC 2008 Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab 19:340-347
328. McGee EA, Hsueh AJ 2000 Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21:200-214
329. Hurwitz JM, Santoro N 2004 Inhibins, activins, and follistatin in
330. Soules MR, Battaglia DE, Klein NA 1998 Inhibin and reproductive aging in women. Maturitas 30:193-204
331. Long JR, Shu XO, Cai Q, Cai H, Gao YT, Jin F, ZhengW 2006 Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women. Am J Human Biol 55:238-246
332. Mitchell ES, Farin FM, Stapleton PL, Tsai JM, Tao EY, Smith-DiJulio K, WoodsNF2008 Association of estrogenrelated polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause 15:105-111
333. Zhang F, Xiong DH, Wang W, Shen H, Xiao P, Yang F, Recker RR, DengHW2006HDCgene polymorphisms are associated with age at natural menopause in Caucasian women. Biochem Biophys Res Commun 348:1378-1382